Differential Expression of lincRNA-ROR Spliced Transcript Variants in Breast Cancer.

ABSTRACT:

Background

We investigated the expression pattern of a human stem cell-specific, large intergenic noncoding RNA (lincRNA) regulator of reprogramming (lincRNA-ROR) and its spliced transcript variants in breast tumors. Breast cancer is the leading cause of cancer mortality in women; therefore, finding a reliable diagnostic tumor marker, based on the molecular profile of tumor cells, is warranted.

Methods

qRT-PCR was used to investigate the expression alteration of a specific stem cell-related lincRNA and its spliced transcript variants in breast tumors which provided by the Iran National Tumor Bank (2014-2016). Suitability of lincRNA-ROR and expression alterations of its spliced transcript variants as breast tumor biomarkers were examined by

SUBMITTER: Saadat Akhtar M 

PROVIDER: S-EPMC10113567 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature